Middle East and Africa Stem Cell Therapy Market Size- By Product Type, By Type, By Application, By End User, By Distribution Channel- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Description

Middle East and Africa Stem Cell Therapy Market Introduction and Overview

According to SPER Market Research, 'Middle East and Africa Stem Cell Therapy Market Size - By Product Type, By Type, By Application, By End User, By Distribution Channel - Regional Outlook, Competitive Strategies and Segment Forecast to 2033' states that the Middle East and Africa Stem Cell Therapy Market is estimated to reach USD 158.57 million by 2033 with a CAGR of 10.53%.

Stem cell therapy uses stem cells or derivatives to stimulate tissue repair in dysfunctional or wounded areas. It is the next stage of organ transplantation, replacing donor organs, which are in short supply. Adult stem cells, such as those produced from adipose tissue, bone marrow, and placental or umbilical stem cells, are found in tiny amounts in most organs.

The COVID-19 epidemic has had a tremendous influence on the healthcare sector, notably the stem cell therapy market in the Middle East and Africa. The pandemic interrupted clinical trials and healthcare systems, but it also highlighted the potential of regenerative medicine in treating COVID-19 long-term effects such as organ damage and immune system dysfunction.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period: 2024-2033

Segments covered: By Product Type, By Type, By Application, By End User, By Distribution Channel

Regions covered: South Africa, Egypt, United Arab Emirates, Rest of Middle East and Africa.

Companies Covered: U.S. Stem Cell, Inc, STEMPEUTICS RESEARCH PVT LTD, Pluristem Inc, NuVasive, Inc, Mesoblast Limited, Athersys, Inc, Takeda Pharmaceutical Company Limited, Medipost Co., Ltd, JCR Pharmaceuticals Co., Ltd, Pharmicell Co., Ltd

Middle East and Africa Stem Cell Therapy Market Segmentation:

By Product Type: Based on the Product Type, Middle East and Africa Stem Cell Therapy Market is segmented as; Bone Marrow Derived Mesenchymal Cells, Placental or Umbilical Stem Cell, Adipose Tissue Derived Mesenchymal Stem Cells, and Others.

By Application: Based on the Application, Middle East and Africa Stem Cell Therapy Market is segmented as; Musculoskeletal Disorders, Acute Graft-Versus-Host Disease, Wounds and Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, and Others.

By End User: Based on the End User, Middle East and Africa Stem Cell Therapy Market is segmented as; Hospitals and Surgical Centers, Therapeutic Companies, Services Companies, and Others

By Region: This research also includes data for South Africa, Egypt, United Arab Emirates, Rest of Middle East and Africa

Product Code: BIOT2401

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impacts of the Middle East and Africa Stem Cell Therapy Market.

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Middle East and Africa Stem Cell Therapy Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Middle East and Africa Stem Cell Therapy Market

7. Middle East and Africa Stem Cell Therapy Market, By Product Type (USD Million) 2020-2033

7.1. Middle East and Africa Stem Cell Therapy Market Size, Share and Forecast, By Product Type, 2020-2026
7.2. Middle East and Africa Stem Cell Therapy Market Size, Share and Forecast, By Product Type, 2027-2033
7.3. Bone Marrow Derived Mesenchymal Stem Cells
7.4. Placental or Umbilical Stem Cell
7.5. Adipose Tissue Derived Mesenchymal Stem Cells
7.6. Others

8. Middle East and Africa Stem Cell Therapy Market, By Type (USD Million) 2020-2033

8.1. Middle East and Africa Stem Cell Therapy Market Size, Share and Forecast, By Type, 2020-2026
8.2. Middle East and Africa Stem Cell Therapy Market Size, Share and Forecast, By Type, 2027-2033
8.3. Allogeneic Stem Cell Therapy
8.4. Autologous Stem Cell Therapy

9. Middle East and Africa Stem Cell Therapy Market, By Application (USD Million) 2020-2033

9.1. Middle East and Africa Stem Cell Therapy Market Size, Share and Forecast, By Application, 2020-2026
9.2. Middle East and Africa Stem Cell Therapy Market Size, Share and Forecast, By Application, 2027-2033
9.3. Musculoskeletal Disorders
9.4. Wounds and Injuries
9.5. Acute Graft-Versus-Host Disease (AGVHD)
9.6. Surgeries
9.7. Gastrointestinal Diseases
9.8. Cardiovascular Diseases
9.9. Others

10. Middle East and Africa Stem Cell Therapy Market, By End User (USD Million) 2020-2033

10.1. Middle East and Africa Stem Cell Therapy Market Size, Share and Forecast, By End User, 2020-2026
10.2. Middle East and Africa Stem Cell Therapy Market Size, Share and Forecast, By End User, 2027-2033
10.3. Hospitals and Surgical Centers
10.4. Therapeutic Companies
10.5. Services Companies
10.6. Others

11. Middle East and Africa Stem Cell Therapy Market, By Distribution Channel (USD Million) 2020-2033

11.1. Middle East and Africa Stem Cell Therapy Market Size, Share and Forecast, By Distribution Channel, 2020-2026
11.2. Middle East and Africa Stem Cell Therapy Market Size, Share and Forecast, By Distribution Channel, 2027-2033
11.3. Direct Tenders
11.4. Third Party Distributors

12. Middle East and Africa Stem Cell Therapy Market Forecast, 2020-2033 (USD Million)

12.1. Middle East and Africa Stem Cell Therapy Market Size and Market Share

13. Middle East and Africa Stem Cell Therapy Market, By Region, 2020-2033 (USD Million)

13.1. Middle East and Africa Stem Cell Therapy Market Size and Market Share By Region (2020-2026)
13.2. Middle East and Africa Stem Cell Therapy Market Size and Market Share By Region (2027-2033)
13.3. South Africa
13.4. Egypt
13.5. United Arab Emirates
13.6. Rest of Middle East and Africa

14. Company Profile

14.1. U.S. Stem Cell, Inc
- 14.1.1. Company details
- 14.1.2. Financial outlook
- 14.1.3. Product summary
- 14.1.4. Recent developments
14.2. STEMPEUTICS RESEARCH PVT LTD
- 14.2.1. Company details
- 14.2.2. Financial outlook
- 14.2.3. Product summary
- 14.2.4. Recent developments
14.3. Pluristem Inc
- 14.3.1. Company details
- 14.3.2. Financial outlook
- 14.3.3. Product summary
- 14.3.4. Recent developments
14.4. NuVasive, Inc
- 14.4.1. Company details
- 14.4.2. Financial outlook
- 14.4.3. Product summary
- 14.4.4. Recent developments
14.5. Mesoblast Limited
- 14.5.1. Company details
- 14.5.2. Financial outlook
- 14.5.3. Product summary
- 14.5.4. Recent developments
14.6. Athersys, Inc
- 14.6.1. Company details
- 14.6.2. Financial outlook
- 14.6.3. Product summary
- 14.6.4. Recent developments
14.7. Takeda Pharmaceutical Company Limited
- 14.7.1. Company details
- 14.7.2. Financial outlook
- 14.7.3. Product summary
- 14.7.4. Recent developments
14.8. Medipost Co., Ltd
- 14.8.1. Company details
- 14.8.2. Financial outlook
- 14.8.3. Product summary
- 14.8.4. Recent developments
14.9. JCR Pharmaceuticals Co., Ltd
- 14.9.1. Company details
- 14.9.2. Financial outlook
- 14.9.3. Product summary
- 14.9.4. Recent developments
14.10. Pharmicell Co., Ltd
- 14.10.1. Company details
- 14.10.2. Financial outlook
- 14.10.3. Product summary
- 14.10.4. Recent developments
14.11. Hope Biosciences
- 14.11.1. Company details
- 14.11.2. Financial outlook
- 14.11.3. Product summary
- 14.11.4. Recent developments
14.12. BrainStorm Cell Therapeutics Inc
- 14.12.1. Company details
- 14.12.2. Financial outlook
- 14.12.3. Product summary
- 14.12.4. Recent developments
14.13. Others